Z, O., HA, E., MNA, Y., MJ, S., MA, A., A, A., . . . A, A. (2025). Semaglutide in Patients with Obesity and Heart Failure Irrespective of Their Baseline Ejection Fraction: An Efficacy and Safety Meta-analysis of Randomized Controlled Trials. Cardiology in review. https://doi.org/10.1097/CRD.0000000000000925
Chicago Style (17th ed.) CitationZ, Otmani, et al. "Semaglutide in Patients with Obesity and Heart Failure Irrespective of Their Baseline Ejection Fraction: An Efficacy and Safety Meta-analysis of Randomized Controlled Trials." Cardiology in Review 2025. https://doi.org/10.1097/CRD.0000000000000925.
MLA (9th ed.) CitationZ, Otmani, et al. "Semaglutide in Patients with Obesity and Heart Failure Irrespective of Their Baseline Ejection Fraction: An Efficacy and Safety Meta-analysis of Randomized Controlled Trials." Cardiology in Review, 2025, https://doi.org/10.1097/CRD.0000000000000925.